adenosine antagonists (NIH)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameadenosine antagonists (NIH)
Drug Alias NameCGS-15943 derivatives (NIH)adenosine a2 antagonists (NIH)adenosine A3 antagonists (NIH)MRS-1186MRS-1704 +[12] 
ClassificationSmall molecules
Mechanisms of ActionAdenosine A3 receptor antagonistsAdenosine A2 receptor antagonists
TargetsAdenosine A2 receptorAdenosine A3 receptor
Therapy Area/IndicationsIschemiaInflammationHypersensitivity +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsIschemiaInflammationHypersensitivity +[5] 

Other Information

ATC CodeN/A
Related LinksN/A